| abstract |
The invention relates to novel compounds of formula (I) which bind to integrin receptors, wherein G and L have the following meaning: L is a structural element of formula IL, wherein T represents a COOH group or a radical that can be hydrolyzed to obtain COOH and U- represents (XL)a-(CRL<1>RL<2>)b-, -CRL<1>=CRL<2>-, ethylene or =CRL<1>-, wherein a is 0 or 1; b is 0, 1 or 2; XL represents CRL<3>RL<4>, NRL<5>, oxygen or sulfur and G is a structural element of formula IG, wherein the insertion of structural element G can occur in both orientations and XO represents nitrogen or CRG<1>. The invention also relates to the production of said compounds and to their use as medicaments. |